| Ivy M. Alexander, Karla A. Knight - 2006 - 334 páginas
...fractures among older women. Study of Osteoporotic Fractures Research Group. NEnglJMed 1998;339:733-738. Cummings SR, Eckert S, Krueger KA, et al. The effect...trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 1999;281:2189-2197. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet... | |
| Michael F. Lubin, Robert B. Smith, Thomas F. Dodson, Nathan O. Spell, H. Kenneth Walker - 2006 - 743 páginas
...prescribing of hormone replacement therapy. Wellington (NZ): New Zealand Guidelines Group; 2001 May. 21. Cummings, SR, Eckert, S., Krueger, KA et al. The effect...trial. Multiple Outcomes of Raloxifene Evaluation. /. Am. Med. Assoc. 1999; 281(23); 2189-2197. 22. Haynes, B. & Dowsett, M. Clinical pharmacology of... | |
| Robert G. McKinnell - 2006 - 27 páginas
...Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M et al. 1999. The effect of raloxifene on risk of breast cancer...trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281:2189-97. Cunningham M and Matthews HB. 1995. Cell proliferation as a determining factor for the... | |
| Guidubaldo Querci della Rovere, Ruth Warren, John R. Benson - 2005 - 1018 páginas
...Intervention Study (IBIS-1): a randomised prevention trial. Lancet 2002; 360: 817-24. 13. Cummings S, Eckert S, Krueger KA et al. The effect of raloxifene...postmenopausal women. Results from the MORE randomized trial. JAMA 1999; 281: 2189-97. 14. Cauley J, Norton L, Lippman LE et al. Continued breast cancer risk reduction... | |
| Stephen B. Hulley - 2007 - 388 páginas
...the Raloxifene Use for The Heart (RUTH) Study. Am J Cardiol 2001;88: 392-395. 2. MORE Investigators. The effect of raloxifene on risk of breast cancer...Multiple outcomes of raloxifene evaluation. JAMA. 1999;281: 2189-2197. 3. Information about Good Clinical Practices in FDA Code of Federal Regulations... | |
| Guidubaldo Querci della Rovere, Ruth Warren, John R. Benson - 2005 - 1018 páginas
...Intervention Study ÍIBIS-1): a randomised prevention trial. Lancet 2002; 360: 817-24. n. Cummings S. Eckert S, Krueger KA et al. The effect of raloxifene...postmenopausal women. Results from the MORE randomized tria!. JAMA 1999; 281: 2189-97. 14. Cauley J, Norton L. Lippman LE et al. Continued breast cancer risk... | |
| Miriam E. Nelson Ph.D, Sarah Wernick - 2006 - 342 páginas
...Cauley, L. Norton, T. Nickelsen, N. Bjarnason, M. Morrow, M. Lippman, D. Black, J. Glusman et al. (1999). "The effect of raloxifene on risk of breast cancer...postmenopausal women: results from the MORE randomized trial." Journal of the American Medical Association 281(23): 2189-2197. Ettinger, B., D. Black, B. Mitlak,... | |
| Martine J. Piccart, William C. Wood, Chie-Mien Hung, Lawrence J. Solin, Fatima Cardoso - 2007 - 1027 páginas
...during treatment with raloxifene. JAMA 287:216-220 17. Cummings SR, Eckert S, Krueger KA et al (1999) The effect of raloxifene on risk of breast cancer...postmenopausal women: results from the MORE randomized trial. JAMA 281:2189-2197 18. Cuzick J, Baum M (1985) Tamoxifen and contralateral breast cancer. Lancet 2(8449):282... | |
| Jerry Menikoff, Edward P. Richards - 2006 - 336 páginas
...Mutation, 345 New Engl. J. Med. 159 (2001). 27. Steven R. Cummings et al., The Effect ofRaloxifene on Risk of Breast Cancer in Postmenopausal Women: Results from the MORE Randomized Trial, 281 JAMA 2189 (1999). 28. Adele L. Franks and Karen K. Steinberg, Encouraging News from the SERM Frontier,... | |
| J. Patrick O'Leary, Arnold Tabuenca, Lea Rhea Capote - 2008 - 778 páginas
...in breast-cancer prevention trials. Lancet 2003:361:296-300. 217. Cummings SR, Eckert S, Kruger KE, et al. The effect of raloxifene on risk of breast...trial. Multiple outcomes of raloxifene evaluation. JAMA 1999:281:2189-2197. 218. Goss PE, Inge J, Martino S, et al. A randomized trial of letrozole in postmenopausal... | |
| |